Prion Switches Let Yeast Rapidly Evolve Drug Resistance on Demand
Stanford researchers discover prion-based protein assemblies act as reversible mutagenesis switches, enabling rapid adaptation under stress.
Summary
Scientists at Stanford found that yeast cells use prion-like protein clumps as a kind of biological dial to temporarily increase mutation rates when facing tough conditions. These self-assembling proteins alter DNA repair machinery, generating genetic diversity that helps the organism survive stress — then the process can reverse. The same mechanism was found in Candida albicans, a dangerous fungal pathogen, where it speeds up the emergence of resistance to the antifungal drug fluconazole. This challenges the old view that high mutation rates are purely harmful, suggesting cells have evolved elegant, reversible strategies to accelerate evolution when they need it most. The findings have broad implications for understanding how drug resistance arises in pathogens and, more broadly, how epigenetic memory can shape genome stability across generations.
Detailed Summary
Why this matters: Drug resistance is one of the most pressing challenges in modern medicine. Understanding the biological machinery that allows microbes — and potentially cancer cells — to rapidly evolve resistance could unlock new therapeutic targets and inform longevity science by revealing how genomic stability is regulated under stress.
What was studied: Researchers from Stanford's Department of Chemical and Systems Biology investigated whether prion-like protein self-assembly could function as a heritable but reversible switch controlling mutation rates in yeast populations. They examined Saccharomyces cerevisiae strains from diverse ecological niches, including laboratory and clinical isolates, and extended their analysis to the WHO priority fungal pathogen Candida albicans.
Key results: Prion-based switching of DNA repair and recombination proteins was found to alter mutagenesis across yeast populations. This self-templating protein assembly reshapes the activities and interactions of multiple DNA-fidelity factors, increasing genetic diversity under selective pressure while preserving resilience to DNA-damaging (genotoxic) stress. In C. albicans, a key regulator of prion inheritance was shown to accelerate the emergence of fluconazole resistance, a clinically critical finding given this pathogen's global health burden.
Implications: The research suggests that protein self-assembly can create a form of epigenetic memory — heritable changes in cellular behavior that do not involve permanent DNA sequence alterations. This 'mutagenesis tuning' mechanism could represent a conserved evolutionary strategy across diverse organisms. For longevity and medicine, it raises the possibility that similar mechanisms operate in human cancer cells adapting to chemotherapy, or in aging tissues accumulating somatic mutations.
Caveats: This study was conducted in yeast and fungal models; direct applicability to human cells remains speculative. The summary is based on the abstract only, and full mechanistic details, experimental scope, and quantitative outcomes require access to the complete paper.
Key Findings
- Prion-like protein assemblies act as reversible switches that temporarily elevate mutation rates in yeast under stress.
- Multiple DNA repair and fidelity proteins are simultaneously altered by this self-templating assembly mechanism.
- In Candida albicans, a prion inheritance regulator accelerates emergence of fluconazole antifungal resistance.
- The mechanism preserves resilience to genotoxic stress while increasing adaptive genetic diversity.
- Protein self-assembly can encode epigenetic memory that influences genome diversification across generations.
Methodology
The study used Saccharomyces cerevisiae populations from laboratory and clinical sources, examining prion-switching behavior in DNA repair proteins under selective pressure. The team also investigated Candida albicans, a divergent fungal pathogen separated from S. cerevisiae by approximately 300 million years of evolution, to assess conservation of the mechanism. Specific experimental techniques are not detailed in the abstract.
Study Limitations
This summary is based on the abstract only; full methodology, quantitative data, and detailed mechanistic findings are not available. All experimental work was conducted in yeast models (S. cerevisiae and C. albicans), and extrapolation to human cells or clinical scenarios requires further research. The reversibility and heritability claims, while theoretically supported by modeling cited in the abstract, need verification in broader biological contexts.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.